Arrowhead Pharmaceuticals Breaks Ground on Massive Drug Manufacturing Plant in Wisconsin – Los Angeles Business Journal

Pasadena-based Arrowhead Prescribed drugs Inc. earlier this month broke floor on a large 285,000-square-foot drug manufacturing and help plant in Wisconsin.
The plant, situated on 13 acres in Verona, a suburb of the state capital of Madison, is slated to be accomplished in 2024. It’s going to include a 160,000-square-foot drug manufacturing facility and a 125,000-square-foot laboratory and workplace facility to help improvement and analytical actions. The lab and workplace complicated are set to be accomplished subsequent yr.
In line with studies, the plant will price about $250 million.

The plant will develop and manufacture the array of medicine which are in Arrowhead’s pipeline. All of the medication are based mostly on a platform that makes use of RNA to “flip off” the genes that trigger all kinds of ailments. RNA is the molecule that controls the expression of genes on a cell’s DNA strands.

To assist in constructing the plant, Arrowhead introduced on the Might 9 groundbreaking that it had been awarded as a lot as $18.5 million in authorities funding, consisting of as much as $16 million in financing from town of Verona and as a lot as $2.5 million in refundable tax credit from the state of Wisconsin.

Arrowhead’s largest drug manufacturing plant is already situated in Wisconsin, a 111,000-square-foot facility in Madison that employs roughly 200 of its 329 companywide staff, in line with the corporate’s annual report, which was launched final fall.
“Now we have had a productive and mutually helpful relationship with the native biotech group and broader enterprise group within the higher Madison, Wisconsin space for a few years,” Christopher Anzalone, Arrowhead’s chief govt, stated within the groundbreaking announcement.

Along with its Wisconsin amenities, Arrowhead has 38 staff at a 21,000-square-foot manufacturing facility in San Diego and 93 staff at its 48,000-square-foot headquarters in Pasadena. The lease time period on the San Diego facility ends subsequent January, whereas the headquarters lease ends in 2027.

Regardless of these lease expirations and its vastly expanded presence in Wisconsin, Arrowhead just isn’t giving up on California. Final November, Arrowhead signed a 15-year lease for 144,000 sq. ft of workplace and lab area to be in-built San Diego.